iDrug-Target

iDrug-Target predicts interactions between drug compounds and protein targets to improve interaction discovery for drug design by addressing class imbalance in benchmark datasets.


Key Features:

  • Drug–protein interaction prediction: Predicts interactions between drug compounds and protein targets at the compound–target pair level.
  • Imbalanced dataset handling: Applies the neighborhood cleaning rule and the synthetic minority over-sampling technique (SMOTE) to balance positive (interactive) and negative (non-interactive) subsets in skewed benchmark datasets.
  • Optimized benchmark datasets: Produces optimized benchmark datasets with balanced positive and negative subsets for improved model training and evaluation.
  • Specialized sub-predictors: Implements four sub-predictors—iDrug-GPCR for G-protein-coupled receptors (GPCRs), iDrug-Chl for ion channels, iDrug-Ezy for enzymes, and iDrug-NR for nuclear receptors—to target specific protein families.
  • Validation: Validates predictions against experiment-confirmed datasets.
  • Misclassification reduction: Specifically addresses the tendency to misclassify interactive pairs in datasets with disproportionately more non-interactive pairs.

Scientific Applications:

  • Drug–protein interaction discovery: Enables identification of potential interactions between small-molecule drugs and protein targets.
  • Family-specific interaction identification: Identifies interactions specific to GPCRs, ion channels, enzymes, and nuclear receptors using dedicated sub-predictors.
  • Support for drug design: Provides interaction predictions to inform drug design and target prioritization.
  • Benchmark preparation for computational studies: Generates balanced benchmark datasets for training and evaluating predictive models.

Methodology:

Imbalanced benchmark datasets are processed using the neighborhood cleaning rule and SMOTE to create optimized datasets; four specialized sub-predictors (iDrug-GPCR, iDrug-Chl, iDrug-Ezy, iDrug-NR) perform interaction predictions, which are validated against experiment-confirmed datasets.

Topics

Details

Tool Type:
web application
Operating Systems:
Linux, Windows, Mac
Added:
8/3/2017
Last Updated:
11/25/2024

Operations

Publications

Xiao X, Min J, Lin W, Liu Z, Cheng X, Chou K. iDrug-Target: predicting the interactions between drug compounds and target proteins in cellular networking via benchmark dataset optimization approach. Journal of Biomolecular Structure and Dynamics. 2015;33(10):2221-2233. doi:10.1080/07391102.2014.998710. PMID:25513722.

PMID: 25513722
Funding: - National Nature Science Foundation of China: 31260273 - Jiangxi Provincial Foreign Scientific and Technological Cooperation Project: 20120BDH80023 - Natural Science Foundation of Jiangxi Province, China: 20122BAB2010, 20122BAB201044, 20122BAB211033 - LuoDi plan of the Department of Education of JiangXi Province: KJLD12083 - JiangXi Provincial Foundation for Leaders of Disciplines in Science: 20113BCB22008

Documentation

Links